FDA names new No. 2 to re­place re­tir­ing Sher­man

The US Food and Drug Ad­min­is­tra­tion (FDA) an­nounced Mon­day that Dr. Amy Aber­nethy will re­place Rachel Sher­man as Prin­ci­pal Deputy com­mis­sion­er of Food and Drugs – the high­est po­si­tion at the agency that is not a po­lit­i­cal ap­pointee.

Aber­nethy is the for­mer chief med­ical of­fi­cer, chief sci­en­tif­ic of­fi­cer and se­nior vice pres­i­dent, on­col­o­gy, at Flat­iron Health, which is a unit of Roche. Pri­or to that she was a pro­fes­sor of med­i­cine at Duke Uni­ver­si­ty School of Med­i­cine and ran the Cen­ter for Learn­ing Health Care in the Duke Clin­i­cal Re­search In­sti­tute and Duke Can­cer Care Re­search Pro­gram in the Duke Can­cer In­sti­tute.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.